Takeda pulls lung cancer drug from market
Takeda Pharmaceuticals voluntarily withdraws Exkivity (mobocertinib) in the U.S. after a phase 3 trial failed to confirm the lung cancer drug's efficacy.
Source: beckershospitalreview.com
Oluntarily Withdrawing News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oluntarily Withdrawing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oluntarily Withdrawing Today - Breaking & Trending Today